Company profile

Lindus Health

Clinical Trials & Research

Company profile

About Lindus Health

Lindus Health is a next-generation contract research organization (CRO) that fundamentally reimagines clinical trial delivery through integrated technology and accountability. Founded to address the chronic delays and cost overruns plaguing traditional CROs, Lindus operates through a single AI-assisted trial operating system called Citrus that unifies patient recruitment, study operations, and clinical data management. The company's distinctive approach centers on performance-based commercial models with milestone-based payments, aligning financial incentives with sponsor timelines and budgets. Lindus has demonstrated exceptional performance, with 82% of trials completing enrollment on or ahead of schedule compared to the 20% industry average. The company provides full-service clinical trial capabilities spanning study design through database lock, with expertise across cardiometabolic, respiratory, psychiatry, dermatology, women's health, and diagnostics therapeutic areas. Operating with over 160 full-time staff across the US, UK, and Europe with integrated APAC partnerships, Lindus serves biotech and pharmaceutical companies seeking predictable, accountable trial execution. The company's integrated model eliminates the fragmentation typical of traditional CROs by maintaining one team accountable for each program from protocol design through completion, with real-time visibility into enrollment performance and data completeness. With annual team turnover under 12% (less than half the industry average), Lindus has established itself as a technology-forward, operationally excellent partner for sponsors requiring confidence and control over their clinical studies.

Company description Lindus Health official website

Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Lindus Health?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Cardiometabolic
  • Dermatology
  • Diagnostics
  • Psychiatry
  • Respiratory
  • Women's health

Who it serves

  • Biotech companies
  • Pharmaceutical companies

Deployment & integration

Cloud Saas · Hybrid deployment with recorded integration context.

Geographic context

MarketsAPAC (via partnerships) · Europe · United Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

Strategic partnership with Quotient Sciences announced December 2025; finalist for Best Contract Research Organization 2025; finalist for AI Innovation Challenge 2025; Outstanding Patient Recruitment & Retention award 2025

Partnerships

Recorded partners

  • Integrated APAC partnerships
  • Quotient Sciences (strategic partnership announced Dec 2025)
  • Tempus AI (acquisition of Highline Sciences)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Central Patient Identification & Enrollment

Direct-to-patient recruitment integrated with site-based enrollment

Service · HybridCompany source

Citrus

AI-assisted trial operating system for integrated clinical trial delivery

Platform · Cloud SaaSCompany source

Integrated Clinical Trial Delivery

End-to-end CRO services with milestone-based commercial terms

Service · HybridCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Chloral Hydrate in the Treatment of Severe Insomnia When Other Treatments Have Failed: Results From a Real-World Evidence Study (RESTORE).

Nature and science of sleep · Jan 1, 2026

Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected and self-collected vaginal swabs for detecting HPV: a comparative study.

Journal of clinical microbiology · May 14, 2025

Decentralised trials for hearing and tinnitus therapies: Lessons from the Digital thErapy For Improved tiNnitus carE (DEFINE) randomised controlled trial.

PloS one · Jan 1, 2025

Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial.

The British journal of nutrition · Jul 14, 2024

Digital thErapy For Improved tiNnitus carE Study (DEFINE): Protocol for a randomised controlled trial.

PloS one · Jan 1, 2024

Improving clinical trial design using interpretable machine learning based prediction of early trial termination.

Scientific reports · Jan 4, 2023

Clinical validation

Clinical-trial records

CoMind Early Feasibility Study

NCT06368648 · Sponsor · RECRUITING

Examining the Medium-term Effect on Non Inferiority of the Previous Training With the DMD Poppins Clinical for Cognitive, Musical Training in Addition to Bi-monthly Speech and Reading Therapy on Reading Writing Abilities of Pediatric Patients With SLD Reading VS Control Group

NCT06902610 · Sponsor · COMPLETED

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

82% trials completed enrollment on or ahead of timeline

All 28 trials that completed enrollment within past 3 years where Lindus was responsible for enrollment

Under 12% annual team turnover

Less than half the industry average for CRO staff retention

Pharmanovia

Clinical trial execution with cost certainty and partnership model

Cost certainty achieved with real partnership replacing traditional change order-focused CRO relationships

Undisclosed Biotech Client (Eric Haltom, SVP Clinical Operations)

Clinical trial execution for biotech company seeking tight-knit partnership

Achieved partner-level collaboration and execution compared to feeling like 'another fish in the big pond' with larger CROs

Undisclosed Client (Akash Bijlani, Director Global Market Access)

Clinical trial execution with proactive problem-solving

Forever changed clinical trial experience with can-do attitude and above-and-beyond execution

Undisclosed Client (David Zakariaie, Chief Executive Officer)

Clinical trial for technology-based intervention requiring tailored study design

High proactivity and inventive approaches to mitigating potential roadblocks with deep understanding of technology nuances

Undisclosed Client (Dr. Jameel Muzaffar, Chief Science Officer)

Fully decentralized trial execution

Delivered on time and on budget with responsive, professional, adaptable service and seamless enrollment through modern systems

Undisclosed Client (Dr. Navid Khodaparast, Chief Scientific Officer)

Clinical research execution with dedication and transparency

Trial treated as if it were Lindus's own, demonstrating dedication and transparency throughout

Undisclosed Client (Mark Wutke, Chief Executive Officer)

Clinical trial execution with proactive, transparent delivery

Delivered on time and on budget with proactive approach and flexible change management

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Gemma Harrison

Chief Product & Technology Officer

Heather Davis

VP of Clinical Operations

LinkedIn

Luke Twelves

VP of Medical

Richard McCormick

VP of Clinical Solutions

LinkedIn

06 · Company updates

Updates from Lindus Health

Recent articles published on Lindus Health's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Clinical Trials & Research

Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon